Balance Sheet
Accounts PayablesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Receivables: 2019-2024

Historic Receivables for IM Cannabis (IMCC) over the last 6 years, with Dec 2024 value amounting to $10.3 million.

  • IM Cannabis' Receivables fell 21.47% to $9.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $36.9 million, marking a year-over-year increase of 8.26%. This contributed to the annual value of $10.3 million for FY2024, which is 61.48% up from last year.
  • Per IM Cannabis' latest filing, its Receivables stood at $10.3 million for FY2024, which was up 61.48% from $6.4 million recorded in FY2023.
  • Over the past 5 years, IM Cannabis' Receivables peaked at $14.8 million during FY2021, and registered a low of $4.2 million during FY2020.
  • For the 3-year period, IM Cannabis' Receivables averaged around $7.8 million, with its median value being $6.8 million (2022).
  • Its Receivables has fluctuated over the past 5 years, first surged by 252.74% in 2021, then plummeted by 53.74% in 2022.
  • Yearly analysis of 5 years shows IM Cannabis' Receivables stood at $4.2 million in 2020, then surged by 252.74% to $14.8 million in 2021, then plummeted by 53.74% to $6.8 million in 2022, then declined by 6.75% to $6.4 million in 2023, then skyrocketed by 61.48% to $10.3 million in 2024.